Literature DB >> 15580114

Oral cancer risk and molecular markers.

Eduardo Chimenos-Küstner1, Imma Font-Costa, José López-López.   

Abstract

The clinical appearance and, especially, the degree of dysplasia that may be shown by pre-cancerous lesions in the oral cavity suggest a potential for malignisation. An increasing number of studies are seeking new, more specific markers that would help to determine the degree of cell alteration and enable a better understanding of the degree of malignant degeneration of these cells. The present review considers the most recent findings for these markers, grouping them into families: tumour growth markers; markers of tumour suppression and anti-tumour response; angiogenesis markers; markers of tumour invasion and metastatic potential; cell surface markers; intracellular markers; markers derived from arachidonic acid; and enzymatic markers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15580114

Source DB:  PubMed          Journal:  Med Oral Patol Oral Cir Bucal        ISSN: 1698-4447


  9 in total

1.  Characterization of epithelial oral dysplasia in non-smokers: First steps towards precision medicine.

Authors:  L D Rock; M P Rosin; L Zhang; B Chan; B Shariati; D M Laronde
Journal:  Oral Oncol       Date:  2018-02-20       Impact factor: 5.337

2.  Characteristics of benign lymphoadenosis of oral mucosa.

Authors:  Shu-Xia Li; Shi-Feng Yu; Kai-Hua Sun
Journal:  World J Gastroenterol       Date:  2005-08-07       Impact factor: 5.742

3.  Biomarkers in Head and Neck Cancer an Update.

Authors:  Naveed Basheeth; Naishadh Patil
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-06-19

4.  Optical molecular imaging of epidermal growth factor receptor expression to improve detection of oral neoplasia.

Authors:  Nitin Nitin; Kelsey J Rosbach; Adel El-Naggar; Michelle Williams; Ann Gillenwater; Rebecca R Richards-Kortum
Journal:  Neoplasia       Date:  2009-06       Impact factor: 5.715

5.  TWIST and p-Akt immunoexpression in normal oral epithelium, oral dysplasia and in oral squamous cell carcinoma.

Authors:  Bruno-Santos de Freitas Silva; Fernanda-Paula Yamamoto; Flávia-Sirotheau Corrêa Pontes; Sérgio Elias-Vieira Cury; Felipe-Paiva Fonseca; Hélder Antonio-Rebelo Pontes; Décio-dos Santos Pinto-Júnior
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-01-01

Review 6.  Overview of Candida albicans and Human Papillomavirus (HPV) Infection Agents and their Biomolecular Mechanisms in Promoting Oral Cancer in Pediatric Patients.

Authors:  Lorenzo Lo Muzio; Andrea Ballini; Stefania Cantore; Lucrezia Bottalico; Ioannis Alexandros Charitos; Mariateresa Ambrosino; Riccardo Nocini; Annarita Malcangi; Mario Dioguardi; Angela Pia Cazzolla; Edoardo Brauner; Luigi Santacroce; Michele Di Cosola
Journal:  Biomed Res Int       Date:  2021-11-02       Impact factor: 3.411

7.  Expression of human telomerase reverse transcriptase protein in oral epithelial dysplasia and oral squamous cell carcinoma: An immunohistochemical study.

Authors:  Bangalore Nagarajachar Raghunandan; Karpagaselvi Sanjai; Jayalakshmi Kumaraswamy; Lokesh Papaiah; Bhavna Pandey; Bellur MadhavaRao Jyothi
Journal:  J Oral Maxillofac Pathol       Date:  2016 Jan-Apr

8.  Serum big endothelin-1 as a biomarker in oral squamous cell carcinoma patients: an analytical study.

Authors:  Pritam Kumar Mankapure; Suresh Ramchandra Barpande; Jyoti Dilip Bhavthankar; Manda Mandale
Journal:  J Appl Oral Sci       Date:  2015-10       Impact factor: 2.698

9.  Evaluation of immunohistochemical expression of TWIST in oral epithelial dysplasia and squamous cell carcinoma.

Authors:  Mashael S Qahtani; Amal M El-Deeb; Hamdy A M Metwaly
Journal:  Int J Health Sci (Qassim)       Date:  2020 Mar-Apr
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.